293 related articles for article (PubMed ID: 11654437)
1. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
Maloney DM
Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
[No Abstract] [Full Text] [Related]
2. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
Maloney DM
Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
[No Abstract] [Full Text] [Related]
3. Informed consent is binding contract: Dahl v. HEM Pharmaceuticals.
Maloney DM
Hum Res Rep; 1995 Dec; 10(12):4-5. PubMed ID: 11653220
[No Abstract] [Full Text] [Related]
4. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
Schuchardt EJ
Columbia J Law Soc Probl; 1992; 26(1):77-115. PubMed ID: 11651647
[No Abstract] [Full Text] [Related]
5. IRB review of adverse events in investigational drug studies.
Prentice ED; Gordon B
IRB; 1997; 19(6):1-4. PubMed ID: 11656910
[No Abstract] [Full Text] [Related]
6. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
7. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
8. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
9. Can a court order participation in research?
Holder AR
IRB; 1987; 9(4):8-9. PubMed ID: 11649949
[No Abstract] [Full Text] [Related]
10. Emergency trials 'by popular consent.
Kiernan V
New Sci; 1995 Nov; 148(2002):6. PubMed ID: 11656475
[No Abstract] [Full Text] [Related]
11. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
12. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
13. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
Salbu SR
Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141
[No Abstract] [Full Text] [Related]
14. A drug company report: what is the same and what is changing with respect to inclusion/exclusion of women in clinical trials.
Goldmann BJ
Food Drug Law J; 1993; 48(2):169-74. PubMed ID: 11653139
[No Abstract] [Full Text] [Related]
15. Informed consent process is deemed "legally and ethically invalid" by witness.
Maloney DM
Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
[No Abstract] [Full Text] [Related]
16. An update on the PEG-SOD study involving incompetent subjects: FDA permits an exception to informed consent requirements.
Prentice ED; Antonson DL; Leibrock LG; Prabhu VC; Kelso TK; Sears TD
IRB; 1994; 16(1-2):16-8. PubMed ID: 11652322
[No Abstract] [Full Text] [Related]
17. Getting new drugs to people with AIDS: a public policy response to Lansdale.
Cohen MN
Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
[No Abstract] [Full Text] [Related]
18. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
19. Federal agency's final rule says informed consent forms must be dated.
Maloney DM
Hum Res Rep; 1996 Dec; 11(12):1-2. PubMed ID: 11655034
[No Abstract] [Full Text] [Related]
20. Informed consent process and document is criticized in court.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
